Education
About Us
Working with TipRanks
Follow Us
Next Science Ltd (AU:NXS)
:NXS
NXS Stock Chart & Stats
AU$0.14
-AU$0.02(-12.50%)
At close: 4:00 PM EST
AU$0.14
-AU$0.02(-12.50%)
Day’s Range― - ―
52-Week RangeAU$0.06 - AU$0.16
Previous CloseN/A
Volume90.61K
Average Volume (3M)225.68K
Market Cap
AU$42.43M
Enterprise ValueAU$26.18M
Total Cash (Recent Filing)AU$971.24K
Total Debt (Recent Filing)AU$5.30M
Price to Earnings (P/E)―
Beta0.87
Next Earnings
Mar 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding292,625,370
10 Day Avg. Volume482,422
30 Day Avg. Volume225,677
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)6.03
Price to Sales (P/S)0.91
P/FCF Ratio-2.43
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.03
Revenue Forecast (FY)AU$60.71M
Next Science Ltd News
NXS FAQ
What was Next Science Ltd’s price range in the past 12 months?
Next Science Ltd lowest share price was AU$0.06 and its highest was AU$0.15 in the past 12 months.
What is Next Science Ltd’s market cap?
Next Science Ltd’s market cap is AU$42.43M.
When is Next Science Ltd’s upcoming earnings report date?
Next Science Ltd’s upcoming earnings report date is Mar 04, 2026 which is in 81 days.
How were Next Science Ltd’s earnings last quarter?
Next Science Ltd released its earnings results on Aug 28, 2025. The company reported -AU$0.024 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.024.
Is Next Science Ltd overvalued?
According to Wall Street analysts Next Science Ltd’s price is currently Overvalued.
Does Next Science Ltd pay dividends?
Next Science Ltd does not currently pay dividends.
What is Next Science Ltd’s EPS estimate?
Next Science Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Next Science Ltd have?
Next Science Ltd has 292,625,370 shares outstanding.
What happened to Next Science Ltd’s price movement after its last earnings report?
Next Science Ltd reported an EPS of -AU$0.024 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Next Science Ltd?
Currently, no hedge funds are holding shares in AU:NXS
Next Science Ltd Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-20.00%
12-Months-Change
Fundamentals
Return on Equity
-289.70%
Trailing 12-Months
Asset Growth
-19.99%
Trailing 12-Months
Company Description
Next Science Ltd
Next Science Ltd (NXS) is a biotechnology company based in Australia that specializes in developing innovative solutions for the treatment of chronic wounds and biofilm-related infections. The company operates primarily in the healthcare sector, focusing on advancing its proprietary Xbio technology platform, which disrupts biofilm and promotes healing in various medical applications. Next Science's core products include its wound care and sinus healthcare offerings, which are designed to improve patient outcomes and reduce the need for antibiotics.
Technical Analysis
Little Green Pharma Ltd.
―
Medical Developments International Limited
―
Althea Group Holdings Ltd.
―
IDT Australia Limited
―
Cronos Australia Ltd.
―
Options Prices
Currently, No data available
---